Proliferation kinetics in adenomyosis during the menstrual cycle and during oral contraceptive use

Gynecological Endocrinology

Volumn 18, Issue 2, 2004, Pages 101-106

  Maia Jr , H ^a   Maltez, A ^a   Studart, E ^b   Athayde, C ^a   Coutinho, E M ^a  

^a Centro De Pesquisa E Assistencia Em Reproducao Humana   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Adenomyosis Proliferation; Ki 67; p53 Expression; Progestins

Indexed keywords

GESTAGEN; KI 67 ANTIGEN; ORAL CONTRACEPTIVE AGENT; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53;

ADENOMYOSIS; ADULT; ARTICLE; CLIMACTERIUM; CONTROLLED STUDY; ENDOMETRIUM ABLATION; FEMALE; FOLLICULAR PHASE; HUMAN; IMMUNOHISTOCHEMISTRY; KINETICS; LUTEAL PHASE; MAJOR CLINICAL STUDY; MENORRHAGIA; MENSTRUAL CYCLE; ORAL CONTRACEPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; CELL DIVISION; CONTRACEPTIVES, ORAL, COMBINED; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 1342347949     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/09513590310001652982     Document Type: Article

References (20)

1. Ferenczy A. Pathophysiology of adenomyosis. Hum Reprod Update 1998;4:312-22
2. Hendrickson MR, Kempson RL. The uterine corpus. In Sternberg S, ed. Diagnostic Surgical Pathology. Philadelphia: Lippincott Raven, 1994:2091-193
3. Emge LE. The elusive adenomyosis of the uterus: its historical past and its present state of recognition. Am J Obstet Gynecol 1962;83:1541-63
4. Nelson JL, Corson SL. Long term management of adenomyosis with gonadotrophin-releasing hormone agonist. A case report. Fertil Steril 1993; 59:441-3
5. McCausland V, McCausland A. The response of adenomyosis to endometrial ablation/resection. Hum Reprod Update 1998;4:350-9
6. Sotnikova N, Antsiferova I, Malyshkina A. Cytokine network of eutopic and ectopic endometrium in women with adenomyosis. Am J Reprod Immunol 2002;47:251-5
7. Ismail SM, Vandeginste S, Shaw RW. An unusually aggressive case of endometriosis showing p53 expression. J Clin Pathol 2001;54:396-8
8. Toki T, Nakayama K. Proliferative activity and genetic alterations in TP53 in endometriosis. Gynecol Obstet Invest 2000;50(Suppl 1):33-8
9. Nakayma K, Toki T, Zhai YL, et al. Demonstration of focal p53 expression without genetic alterations in endometriotic lesions. Int J Gynecol Pathol 2001;20: 227-31
10. Taskin M, Lallas TA, Shevchuk M, et al. p53 in adenomyosis in endometrial carcinoma patients. Gynecol Oncol 1996;62:241-6
11. Mittal KR, Barwick KW. Endometrial adenocarcinoma involving adenomyosis without true myometrial invasion is characterized by frequent preceding estrogen therapy, low histological grades, and excellent prognosis. Gynecol Oncol 1993;49:197-201
12. Hall JB, Young RH, Nelson JH Jr. The prognostic significance of adenomyosis in endometrial carcinoma. Gynecol Oncol 1984;17:32-40
13. Bratschi HV. Hysteroscopic endometrial resection. Contrib Gynecol Obstet 2000;20:121-36
14. Maia H Jr, Maltez A, Coelho G, et al. Insertion of Mirena following endometrial resection in patients with adenomyosis. J Am Assoc Gynecol Laparosc 2003;10:512-16
15. Levine RI, Cargile CB, Blazes MS, et al. PTEN mutation and micro-satellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. Cancer Res 1998; 58:3254-8
16. Matsumoto Y, Iwasaka T, Yamasaki F, et al. Apoptosis and ki-67 expression in adenomyotic lesions and in the corresponding eutopic endometrium. Obstet Gynecol 1999;94:71-7
17. Robertson WB. The Endometrium. London: Butterworths, 1966:65-70
18. Ryan KM, Phillips AC, Vousden KH. Regulation and function of the p53 tumor suppressor protein. Curr Opin Cell Biol 2001;13:332-7
19. Koshiyama M, Konishi I, Wang DP, et al. Immunohistochemical analysis of p53 over-expression in endometrial carcinoma: inverse correlation with sex steroid receptor status. Virch Arch A Pathol Anat Histopathol 1993;423:265-71
20. King AS, Adas AA, Livolsi VA. Expression and mutation analysis of p53 gene in uterine papillary serous carcinoma. Cancer 1995;75:2700-5